News
🇺🇸 FDA Page 51Latest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 601–612 of 807 articles
Mabwell's Nectin-4 ADC Bulumtatug Fuvedotin Shows Promise in Cervical Cancer Case Report Published in NEJM
Outlook Therapeutics Completes FDA Dispute Resolution Meeting for LYTENAVA Bevacizumab Biosimilar
Follicular Lymphoma Clinical Trials Surge: 45+ Companies Developing New Treatments in 2026
Obsidian Therapeutics OBX-115 Phase 2 Melanoma Data to Be Presented at ASCO 2026
IceCure Medical ProSense Revenue Surges 30% in Q1 2026 as Cryoablation Technology Gains Traction
Nuvalent to Present Pivotal Neladalkib Data from ALKOVE-1 Trial at ASCO 2026 for ALK-Positive Lung Cancer
FDA Approves Merck's IDVYNSO: First Non-INSTI, Tenofovir-Free Two-Drug HIV Treatment
LENZ Therapeutics Submits VIZZ Presbyopia Treatment for UK Approval Following EU Validation
Pasithea Therapeutics' PAS-004 Receives FDA Rare Pediatric Disease Designation for Neurofibromatosis Type 1 Treatment
Clearmind Medicine CMND-100 Meets Primary Safety Endpoint in Alcohol Use Disorder Trial
Sapience Therapeutics ST316 Shows 47% Response Rate in Phase 2 Colorectal Cancer Trial
Tozorakimab Meets Primary Endpoint in Phase III COPD Trial, Shows Significant Reduction in Exacerbations